Stock Analysis on Net
Stock Analysis on Net

Edwards Lifesciences Corp. (NYSE:EW)

This company has been moved to the archive! The financial data has not been updated since February 14, 2022.

Common-Size Income Statement

Edwards Lifesciences Corp., common-size consolidated income statement

Microsoft Excel
12 months ended: Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Net sales 100.00 100.00 100.00 100.00 100.00
Cost of sales -23.87 -24.64 -25.63 -25.23 -25.48
Gross profit 76.13% 75.36% 74.37% 74.77% 74.52%
Selling, general, and administrative expenses -28.55 -28.01 -28.57 -29.24 -28.66
Research and development expenses -17.26 -17.34 -17.31 -16.71 -16.09
Intellectual property litigation income (expenses), net -0.39 -9.24 -0.77 -5.75 2.13
Change in fair value of contingent consideration liabilities, net 2.37 -0.31 0.14 0.15 0.29
Special charges 0.00 0.00 -1.49 -3.12 -0.28
Other operating expenses 0.00 0.00 0.00 0.00 -0.02
Operating income 32.30% 20.46% 26.38% 20.10% 31.89%
Interest expense -0.35 -0.36 -0.48 -0.80 -0.68
Interest income 0.33 0.53 0.74 0.86 0.59
Special gains (charges) 0.00 0.00 0.00 0.19 -1.46
Foreign exchange gains (losses), net 0.10 0.28 0.14 0.18 -0.16
Gain (loss) on investments 0.11 0.01 0.01 -0.05 -0.08
Non-service cost components of net periodic pension benefit credit (cost) -0.01 -0.01 0.00 0.00 0.00
Other 0.04 -0.02 0.05 -0.03 0.02
Other income (expense), net 0.24% 0.26% 0.19% 0.11% -0.22%
Income before provision for income taxes 32.53% 20.90% 26.83% 20.45% 30.13%
Provision for income taxes -3.80 -2.13 -2.75 -1.05 -13.14
Net income 28.73% 18.77% 24.08% 19.40% 16.99%

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

Income statement item Description The company
Operating income The net result for the period of deducting operating expenses from operating revenues. Edwards Lifesciences Corp. operating income as a percentage of net sales decreased from 2019 to 2020 but then increased from 2020 to 2021 exceeding 2019 level.
Income before provision for income taxes Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Edwards Lifesciences Corp. income before provision for income taxes as a percentage of net sales decreased from 2019 to 2020 but then increased from 2020 to 2021 exceeding 2019 level.
Net income The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Edwards Lifesciences Corp. net income as a percentage of net sales decreased from 2019 to 2020 but then increased from 2020 to 2021 exceeding 2019 level.